
Stephen J. Ubl
Stephen J. Ubl is the president and CEO of PhRMA, the leading trade organization representing the pharmaceutical industry in the United States, known for advocating on behalf of drug manufacturers regarding policies that affect their business and the development of new medications.
Not in the pool (under ¢1).
Recent news mentions
Stephen J. Ubl, the president and CEO of PhRMA, argued that the executive order would harm American patients.
President Donald Trump's effort to lower drug costs amounts to price control, expert saysStephen J. Ubl is the president and CEO of PhRMA, opposing Trump's order.
Trump firma orden para que empresas reduzcan precios de medicamentosStephen J. Ubl, president of PhRMA, criticized Trump's plan as a 'bad deal for American patients'.
Proizvođači da sami smanje cijene ljekova koji se izdaju na recept, ili...Stephen J Ubl, president of the Pharmaceutical Research and Manufacturers of America, criticized the executive order.
What's in it, and will it work?Stephen J. Ubl criticized Trump's order, calling it a 'bad deal' for American patients.
Trump firma orden sobre medicamentos; da 30 días a farmacéuticas para bajar costos o tomará medidasStephen J. Ubl, the president and CEO of PhRMA, said in a statement that importing foreign prices will cut billions of dollars from Medicare.
Trump says he’ll set 30-day deadline for drugmakers to lower the cost of prescription drugs
















